2980682-00-4
Chemical Structure
RP-1664
- CAS No.: 2980682-00-4
- Formula:C23H24F2N8O2S
- Molecular Weight:514.55
InChIKey: POKVQQVLRJLUAK-UHFFFAOYSA-N
SMILES: CC1=CC(NC2=NC(N(C3=C(C=C(C=C3F)S(C)(=O)=O)F)C)=NC(C4=CN(C=N4)C)=C2C5CC5)=NN1
Biological Activity: RP-1664 is a selective and orally active PLK4 inhibitor with an IC50 of 3 nM. RP-1664 demonstrates exquisite selectivity over related kinases, including AURKA/B and PLK1. RP-1664 disrupts centriole biogenesis in cancer cells and leads an accumulation of PLK4 and p21 protein. RP-1664 demonstrates increased sensitivity in TRIM37-high-expressing cells or tumors. RP-1664 exhibits anti-tumor activity in breast cancer and neuroblastoma research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RP-1664 | 98.77% | RP-1664 is a selective and orally active PLK4 inhibitor with an IC50 of 3 nM. RP-1664 demonstrates exquisite selectivity over related kinases, including AURKA/B and PLK1. RP-1664 disrupts centriole biogenesis in cancer cells and leads an accumulation of PLK4 and p21 protein. RP-1664 demonstrates increased sensitivity in TRIM37-high-expressing cells or tumors. RP-1664 exhibits anti-tumor activity in breast cancer and neuroblastoma research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.48
HY-128493PLK4-IN-4 -
Similarity Score 0.48
HY-18683Centrinone-B -
Similarity Score 0.48
HY-18682Centrinone -
Similarity Score 0.47
HY-149912CZS-241 -
Similarity Score 0.47
HY-111483Tizaterkib -
Similarity Score 0.45
HY-173006AZ3246 -
Similarity Score 0.45
HY-119216AZ13711265 -
Similarity Score 0.45
HY-16297Abemaciclib methanesulfonate -
Similarity Score 0.44
HY-126299NVS-BPTF-1 -
Explore the MedChemAI to find more analogs